{"id":451,"date":"2026-08-27T10:31:11","date_gmt":"2026-08-27T10:31:11","guid":{"rendered":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"cagrilintide-amylin-analog-phase-2-evidence","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/ar\/cagrilintide-amylin-analog-phase-2-evidence\/","title":{"rendered":"Cagrilintide \u0628\u0627\u0639\u062a\u0628\u0627\u0631\u0647 \u0646\u0638\u064a\u0631 \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0637\u0648\u064a\u0644 \u0627\u0644\u0645\u0641\u0639\u0648\u0644: \u0642\u0631\u0627\u0621\u0629 \u0623\u062f\u0644\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 2"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">Cagrilintide \u0647\u0648 \u0646\u0638\u064a\u0631 \u0623\u0645\u064a\u0644\u064a\u0646 \u0637\u0648\u064a\u0644 \u0627\u0644\u0645\u0641\u0639\u0648\u0644 \u062a\u0645 \u062a\u0637\u0648\u064a\u0631\u0647 \u0644\u0644\u062f\u0631\u0627\u0633\u0629 \u0645\u0631\u0629 \u0648\u0627\u062d\u062f\u0629 \u0623\u0633\u0628\u0648\u0639\u064a\u064b\u0627. \u0625\u0646\u0647 \u064a\u0646\u062a\u0645\u064a \u0625\u0644\u0649 \u0641\u0626\u0629 \u0625\u0634\u0627\u0631\u0627\u062a \u0645\u062e\u062a\u0644\u0641\u0629 \u0639\u0646 \u0645\u0646\u0628\u0647\u0627\u062a \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a GLP-1\u060c \u0639\u0644\u0649 \u0627\u0644\u0631\u063a\u0645 \u0645\u0646 \u0623\u0646 \u0627\u0644\u0628\u0631\u0627\u0645\u062c \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0627\u0644\u0644\u0627\u062d\u0642\u0629 \u0642\u0627\u0645\u062a \u0628\u062a\u0642\u064a\u064a\u0645 \u0643\u0627\u062c\u0631\u064a\u0644\u064a\u0646\u062a\u064a\u062f \u0645\u0639 \u0633\u064a\u0645\u0627\u062c\u0644\u0648\u062a\u064a\u062f.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">\u0627\u0644\u0648\u062c\u0628\u0627\u062a \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629<\/h2><ul class=\"wp-block-list\"><li>Cagrilintide \u0647\u0648 \u0646\u0638\u064a\u0631 \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646. \u0633\u064a\u0645\u0627\u062c\u0644\u0648\u062a\u0627\u064a\u062f \u0647\u0648 \u0646\u0627\u0647\u0636 \u0644\u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a GLP-1.<\/li><li>\u064a\u062c\u0628 \u0627\u0644\u062a\u0645\u064a\u064a\u0632 \u0628\u064a\u0646 \u0623\u062f\u0644\u0629 2 \u0641\u064a \u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u0639\u0627\u0645\u0644 \u0627\u0644\u0648\u0627\u062d\u062f \u0648\u0628\u064a\u0646 \u062a\u062c\u0627\u0631\u0628 \u0645\u062c\u0645\u0648\u0639\u0629 CagriSema \u0627\u0644\u0644\u0627\u062d\u0642\u0629.<\/li><li>\u0648\u0641\u0642\u064b\u0627 \u0644\u0645\u0639\u0644\u0648\u0645\u0627\u062a FDA \u0627\u0644\u062a\u064a \u062a\u0645\u062a \u0645\u0631\u0627\u062c\u0639\u062a\u0647\u0627\u060c \u0641\u0625\u0646 \u0643\u0627\u062c\u0631\u064a\u0644\u064a\u0646\u062a\u064a\u062f \u0644\u064a\u0633 \u0623\u062d\u062f \u0645\u0643\u0648\u0646\u0627\u062a \u0627\u0644\u062f\u0648\u0627\u0621 \u0627\u0644\u0645\u0639\u062a\u0645\u062f \u0645\u0646 FDA.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1672\" height=\"941\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research.png\" alt=\"\u0628\u0627\u062d\u062b \u064a\u0631\u0627\u062c\u0639 \u062b\u0644\u0627\u062b\u0629 \u0645\u0633\u0627\u0631\u0627\u062a \u0644\u0625\u0634\u0627\u0631\u0629 \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a \u0627\u0644\u0628\u0628\u062a\u064a\u062f \u0641\u064a \u0645\u062e\u062a\u0628\u0631 \u0627\u0644\u0628\u064a\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062c\u0632\u064a\u0626\u064a\u0629\" class=\"wp-image-442\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research.png 1672w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-300x169.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-1024x576.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-768x432.png 768w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-1536x864.png 1536w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><figcaption class=\"wp-element-caption\">\u0631\u0633\u0645 \u062a\u0648\u0636\u064a\u062d\u064a \u0645\u062e\u062a\u0628\u0631\u064a \u0623\u0635\u0644\u064a \u0644\u0623\u0628\u062d\u0627\u062b \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a \u0627\u0644\u0628\u0628\u062a\u064a\u062f\u061b \u0627\u0644\u0645\u0633\u0627\u0631\u0627\u062a \u0645\u0641\u0627\u0647\u064a\u0645\u064a\u0629 \u0648\u0644\u0627 \u062a\u062d\u062a\u0648\u064a \u0639\u0644\u0649 \u0628\u064a\u0627\u0646\u0627\u062a \u062a\u062c\u0631\u064a\u0628\u064a\u0629.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">\u0644\u0645\u0627\u0630\u0627 \u064a\u0639\u062a\u0628\u0631 \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0645\u0633\u0627\u0631\u064b\u0627 \u0628\u062d\u062b\u064a\u064b\u0627 \u0645\u062a\u0645\u064a\u0632\u064b\u0627<\/h2><p class=\"wp-block-paragraph\">\u064a\u062a\u0645 \u0625\u0641\u0631\u0627\u0632 \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0645\u0639 \u0627\u0644\u0623\u0646\u0633\u0648\u0644\u064a\u0646 \u0648\u064a\u0634\u0627\u0631\u0643 \u0641\u064a \u0627\u0644\u0625\u0634\u0627\u0631\u0627\u062a \u0627\u0644\u0645\u062a\u0639\u0644\u0642\u0629 \u0628\u0627\u0644\u0645\u063a\u0630\u064a\u0627\u062a. \u062a\u0645 \u062a\u0635\u0645\u064a\u0645 Cagrilintide \u0644\u0644\u062a\u0639\u0631\u0636 \u0627\u0644\u0645\u0645\u062a\u062f \u0628\u0627\u0644\u0646\u0633\u0628\u0629 \u0644\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0627\u0644\u0623\u0635\u0644\u064a. \u0625\u0646 \u0639\u0644\u0645 \u0627\u0644\u0635\u064a\u062f\u0644\u0629 \u0627\u0644\u0645\u0633\u062a\u0642\u0628\u0644\u064a \u0648\u0627\u0644\u062a\u0635\u0645\u064a\u0645 \u0627\u0644\u062c\u0632\u064a\u0626\u064a \u063a\u064a\u0631 \u0642\u0627\u0628\u0644\u064a\u0646 \u0644\u0644\u062a\u0628\u062f\u064a\u0644 \u0645\u0639 GLP-1 \u0623\u0648 GIP \u0623\u0648 \u0646\u0627\u0647\u0636\u0629 \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a \u0627\u0644\u062c\u0644\u0648\u0643\u0627\u062c\u0648\u0646.<\/p><h2 class=\"wp-block-heading\">\u0645\u0627 \u0627\u0644\u0630\u064a \u062a\u0633\u0627\u0647\u0645 \u0628\u0647 \u062a\u062c\u0631\u0628\u0629 2 \u0641\u064a \u0627\u0644\u0645\u0631\u062d\u0644\u0629<\/h2><p class=\"wp-block-paragraph\">\u0642\u0627\u0631\u0646\u062a \u062a\u062c\u0631\u0628\u0629 2 \u0630\u0627\u062a \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u0645\u062c\u0645\u0648\u0639\u0627\u062a \u0645\u062a\u0639\u062f\u062f\u0629 \u0645\u0646 \u062c\u0631\u0639\u0627\u062a \u0643\u0627\u062c\u0631\u064a\u0644\u064a\u0646\u062a\u064a\u062f \u0645\u0639 \u0627\u0644\u062f\u0648\u0627\u0621 \u0627\u0644\u0648\u0647\u0645\u064a \u0648\u0645\u0642\u0627\u0631\u0646\u0629 \u0646\u0634\u0637\u0629 \u0644\u062f\u0649 \u0627\u0644\u0628\u0627\u0644\u063a\u064a\u0646 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0632\u064a\u0627\u062f\u0629 \u0627\u0644\u0648\u0632\u0646 \u0623\u0648 \u0627\u0644\u0633\u0645\u0646\u0629. \u0648\u0642\u0627\u0645 \u0628\u062a\u0642\u064a\u064a\u0645 \u0627\u0644\u062a\u063a\u064a\u0631 \u0641\u064a \u0648\u0632\u0646 \u0627\u0644\u062c\u0633\u0645 \u0648\u0633\u0644\u0627\u0645\u062a\u0647 \u062e\u0644\u0627\u0644 \u0641\u062a\u0631\u0629 \u0627\u0644\u062f\u0631\u0627\u0633\u0629. \u062f\u0639\u0645\u062a \u0627\u0644\u0648\u0631\u0642\u0629 \u0627\u0644\u062a\u0637\u0648\u064a\u0631 \u0627\u0644\u0645\u0633\u062a\u0645\u0631 \u0648\u0644\u0643\u0646\u0647\u0627 \u0644\u0645 \u062a\u062c\u0639\u0644 \u0645\u0646 \u062f\u0648\u0627\u0621 \u0643\u0627\u062c\u0631\u064a\u0644\u064a\u0646\u062a\u064a\u062f \u062f\u0648\u0627\u0621\u064b \u0645\u0639\u062a\u0645\u062f\u064b\u0627.<\/p><p class=\"wp-block-paragraph\">\u0639\u0646\u062f \u062a\u0644\u062e\u064a\u0635 \u0627\u0644\u062a\u062c\u0631\u0628\u0629\u060c \u0641\u0625\u0646 \u0627\u0644\u062a\u0641\u0627\u0635\u064a\u0644 \u0627\u0644\u0645\u0641\u064a\u062f\u0629 \u0647\u064a \u0639\u062f\u062f \u0627\u0644\u0633\u0643\u0627\u0646\u060c \u0648\u0627\u0644\u0639\u0634\u0648\u0627\u0626\u064a\u0629\u060c \u0648\u0627\u0644\u0645\u0642\u0627\u0631\u0646\u0629\u060c \u0648\u0627\u0644\u0645\u062f\u0629\u060c \u0648\u0646\u0642\u0637\u0629 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u064a\u0629\u060c \u0648\u0646\u0645\u0637 \u0627\u0644\u0623\u062d\u062f\u0627\u062b \u0627\u0644\u0636\u0627\u0631\u0629. \u0625\u0646 \u0646\u0633\u062e \u0627\u0644\u062d\u062f \u0627\u0644\u0623\u0642\u0635\u0649 \u0644\u0644\u0646\u0633\u0628\u0629 \u0627\u0644\u0645\u0626\u0648\u064a\u0629 \u0628\u062f\u0648\u0646 \u062a\u0644\u0643 \u0627\u0644\u0645\u0624\u0647\u0644\u0627\u062a \u0644\u0627 \u064a\u0639\u062f \u0645\u0631\u0627\u062c\u0639\u0629 \u0643\u0627\u0641\u064a\u0629 \u0644\u0644\u0623\u062f\u0644\u0629.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>\u0641\u0626\u0629 \u0627\u0644\u062c\u0632\u064a\u0621<\/strong><span>\u0646\u0638\u064a\u0631 \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0637\u0648\u064a\u0644 \u0627\u0644\u0645\u0641\u0639\u0648\u0644<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u0646\u0648\u0639 \u0627\u0644\u0623\u062f\u0644\u0629<\/strong><span>\u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0628\u0634\u0631\u064a\u0629 2<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u062d\u062f\u0648\u062f \u0627\u0644\u062a\u0646\u0645\u064a\u0629<\/strong><span>\u0627\u0644\u062a\u062d\u0642\u064a\u0642\u061b \u0644\u0627 \u064a\u0639\u0627\u062f\u0644 \u0645\u0646\u062a\u062c\u0627\u062a \u0633\u064a\u0645\u0627\u062c\u0644\u0648\u062a\u064a\u062f \u0627\u0644\u0645\u0639\u062a\u0645\u062f\u0629<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">\u0627\u0644\u0648\u0643\u064a\u0644 \u0627\u0644\u0648\u062d\u064a\u062f \u0644\u064a\u0633 \u0647\u0648 \u0646\u0641\u0633\u0647 CagriSema<\/h2><p class=\"wp-block-paragraph\">\u064a\u0634\u064a\u0631 CagriSema \u0625\u0644\u0649 \u0627\u0644\u062a\u0646\u0627\u0648\u0644 \u0627\u0644\u0645\u062a\u0632\u0627\u0645\u0646 \u0644\u0640 cagrilintide \u0648semaglutide \u0641\u064a \u0628\u0631\u0627\u0645\u062c \u0633\u0631\u064a\u0631\u064a\u0629 \u0645\u062d\u062f\u062f\u0629. \u0644\u0627 \u064a\u0645\u0643\u0646 \u062a\u0642\u062f\u064a\u0645 \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0645\u0646 \u0647\u0630\u0647 \u0627\u0644\u0645\u062c\u0645\u0648\u0639\u0629 \u0643\u0646\u062a\u0627\u0626\u062c \u0643\u0627\u062c\u0631\u064a\u0644\u064a\u0646\u062a\u064a\u062f \u0641\u0642\u0637\u060c \u0648\u0644\u0627 \u062a\u062a\u062d\u0642\u0642 \u0623\u064a \u0645\u0646 \u0645\u062c\u0645\u0648\u0639\u0627\u062a \u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0645\u0646 \u0635\u062d\u0629 \u0627\u0644\u0645\u0632\u064a\u062c \u0627\u0644\u0645\u0642\u062f\u0645 \u0628\u0634\u0643\u0644 \u0645\u0633\u062a\u0642\u0644 \u0645\u0627 \u0644\u0645 \u064a\u062a\u0645 \u0625\u062b\u0628\u0627\u062a \u0627\u0644\u062a\u0643\u0627\u0641\u0624 \u0648\u062c\u0648\u062f\u0629 \u0627\u0644\u0645\u0646\u062a\u062c.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u062f\u0644\u064a\u0644 \u0642\u0627\u0626\u0645 \u0639\u0644\u0649 \u0627\u0644\u0645\u0635\u062f\u0631 \u0644\u0635\u064a\u062f\u0644\u0629 \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0641\u064a \u0643\u0627\u062c\u0631\u064a\u0644\u064a\u0646\u062a\u064a\u062f\u060c \u0648\u062a\u0635\u0645\u064a\u0645 \u062a\u062c\u0631\u0628\u0629 2 \u0644\u0644\u0645\u0631\u062d\u0644\u0629 \u0648\u0627\u0644\u062d\u062f\u0648\u062f \u0628\u064a\u0646 \u0627\u0644\u0623\u062f\u0644\u0629 \u0627\u0644\u0641\u0631\u062f\u064a\u0629 \u0648\u0627\u0644\u0645\u0631\u0643\u0628\u0629.<\/p>","protected":false},"author":1,"featured_media":621,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"320","pim_article_type":"Clinical evidence review","pim_evidence_level":"Randomized phase 2 human trial; investigational single-agent context","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-27","pim_editorial_note":"Source-checked against the linked primary or authoritative records on 2026-08-27. This is an evidence summary, not independent peer review, medical advice or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"Once-weekly cagrilintide in people with overweight and obesity \u2014 phase 2 trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34798060\/\",\"note\":\"Primary randomized phase 2 record; PMID 34798060.\"},{\"title\":\"FDA information on cagrilintide and other unapproved GLP-1-related products\",\"url\":\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss\",\"note\":\"Current regulatory-status boundary.\"}]","footnotes":""},"categories":[18],"tags":[],"class_list":["post-451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-reviews"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cagrilintide as a Long-Acting Amylin Analog: Reading the Phase 2 Evidence - NHD<\/title>\n<meta name=\"description\" content=\"A source-grounded guide to cagrilintide\u2019s amylin-receptor pharmacology, phase 2 trial design and the boundary between single-agent and combination evidence.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/ar\/cagrilintide-amylin-analog-phase-2-evidence\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cagrilintide as a Long-Acting Amylin Analog: Reading the Phase 2 Evidence\" \/>\n<meta property=\"og:description\" content=\"A source-grounded guide to cagrilintide\u2019s amylin-receptor pharmacology, phase 2 trial design and the boundary between single-agent and combination evidence.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/ar\/cagrilintide-amylin-analog-phase-2-evidence\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T10:31:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Cagrilintide as a Long-Acting Amylin Analog: Reading the Phase 2 Evidence\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/\"},\"wordCount\":284,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp\",\"articleSection\":[\"Evidence Reviews\"],\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/\",\"name\":\"Cagrilintide as a Long-Acting Amylin Analog: Reading the Phase 2 Evidence - NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"A source-grounded guide to cagrilintide\u2019s amylin-receptor pharmacology, phase 2 trial design and the boundary between single-agent and combination evidence.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cagrilintide-amylin-analog-phase-2-evidence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cagrilintide as a Long-Acting Amylin Analog: Reading the Phase 2 Evidence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/ar\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cagrilintide \u0628\u0627\u0639\u062a\u0628\u0627\u0631\u0647 \u0646\u0638\u064a\u0631 \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0637\u0648\u064a\u0644 \u0627\u0644\u0645\u0641\u0639\u0648\u0644: \u0642\u0631\u0627\u0621\u0629 \u0623\u062f\u0644\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 2 - NHD","description":"\u062f\u0644\u064a\u0644 \u0642\u0627\u0626\u0645 \u0639\u0644\u0649 \u0627\u0644\u0645\u0635\u062f\u0631 \u0644\u0635\u064a\u062f\u0644\u0629 \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0641\u064a \u0643\u0627\u062c\u0631\u064a\u0644\u064a\u0646\u062a\u064a\u062f\u060c \u0648\u062a\u0635\u0645\u064a\u0645 \u062a\u062c\u0631\u0628\u0629 2 \u0644\u0644\u0645\u0631\u062d\u0644\u0629 \u0648\u0627\u0644\u062d\u062f\u0648\u062f \u0628\u064a\u0646 \u0627\u0644\u0623\u062f\u0644\u0629 \u0627\u0644\u0641\u0631\u062f\u064a\u0629 \u0648\u0627\u0644\u0645\u0631\u0643\u0628\u0629.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/ar\/cagrilintide-amylin-analog-phase-2-evidence\/","og_locale":"ar_AR","og_type":"article","og_title":"Cagrilintide as a Long-Acting Amylin Analog: Reading the Phase 2 Evidence","og_description":"A source-grounded guide to cagrilintide\u2019s amylin-receptor pharmacology, phase 2 trial design and the boundary between single-agent and combination evidence.","og_url":"https:\/\/nhdbio.com\/ar\/cagrilintide-amylin-analog-phase-2-evidence\/","og_site_name":"NHD","article_published_time":"2026-08-27T10:31:11+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"NHD Technical Team","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Cagrilintide as a Long-Acting Amylin Analog: Reading the Phase 2 Evidence","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/"},"wordCount":284,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp","articleSection":["Evidence Reviews"],"inLanguage":"ar","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/","url":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/","name":"Cagrilintide \u0628\u0627\u0639\u062a\u0628\u0627\u0631\u0647 \u0646\u0638\u064a\u0631 \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0637\u0648\u064a\u0644 \u0627\u0644\u0645\u0641\u0639\u0648\u0644: \u0642\u0631\u0627\u0621\u0629 \u0623\u062f\u0644\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 2 - NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"\u062f\u0644\u064a\u0644 \u0642\u0627\u0626\u0645 \u0639\u0644\u0649 \u0627\u0644\u0645\u0635\u062f\u0631 \u0644\u0635\u064a\u062f\u0644\u0629 \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a \u0627\u0644\u0623\u0645\u064a\u0644\u064a\u0646 \u0641\u064a \u0643\u0627\u062c\u0631\u064a\u0644\u064a\u0646\u062a\u064a\u062f\u060c \u0648\u062a\u0635\u0645\u064a\u0645 \u062a\u062c\u0631\u0628\u0629 2 \u0644\u0644\u0645\u0631\u062d\u0644\u0629 \u0648\u0627\u0644\u062d\u062f\u0648\u062f \u0628\u064a\u0646 \u0627\u0644\u0623\u062f\u0644\u0629 \u0627\u0644\u0641\u0631\u062f\u064a\u0629 \u0648\u0627\u0644\u0645\u0631\u0643\u0628\u0629.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cagrilintide-amylin-analog-phase-2-evidence-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/cagrilintide-amylin-analog-phase-2-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Cagrilintide as a Long-Acting Amylin Analog: Reading the Phase 2 Evidence"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"\u0645\u0648\u0627\u062f \u062e\u0627\u0645 \u0628\u0628\u062a\u064a\u062f\u064a\u0629 \u0648\u062a\u062e\u0644\u064a\u0642 \u0627\u0644\u0628\u0628\u062a\u064a\u062f\u0627\u062a \u062d\u0633\u0628 \u0627\u0644\u0637\u0644\u0628","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u0627\u0644\u0641\u0631\u064a\u0642 \u0627\u0644\u0641\u0646\u064a NHD","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"\u064a\u062d\u062a\u0641\u0638 \u0641\u0631\u064a\u0642 NHD \u0627\u0644\u0641\u0646\u064a \u0628\u0648\u062b\u0627\u0626\u0642 \u0643\u062a\u0627\u0644\u0648\u062c \u0627\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0628\u062d\u062b\u064a \u0648\u0645\u0644\u062e\u0635\u0627\u062a \u0627\u0644\u0623\u062f\u0644\u0629. \u062a\u0631\u062a\u0628\u0637 \u0627\u0644\u0645\u0642\u0627\u0644\u0627\u062a \u0627\u0644\u062a\u064a \u062a\u0645\u062a \u0645\u0631\u0627\u062c\u0639\u062a\u0647\u0627 \u0628\u0627\u0644\u0623\u0648\u0631\u0627\u0642 \u0627\u0644\u062a\u064a \u062a\u0645\u062a \u0645\u0631\u0627\u062c\u0639\u062a\u0647\u0627 \u0645\u0646 \u0642\u0628\u0644 \u0627\u0644\u0646\u0638\u0631\u0627\u0621\u060c \u0648\u0633\u062c\u0644\u0627\u062a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0648\u0627\u0644\u0633\u062c\u0644\u0627\u062a \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629\u060c \u0648\u062a\u062d\u062a\u0641\u0638 \u0628\u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0627\u0644\u0641\u0627\u0631\u063a\u0629 \u0648\u0642\u064a\u0648\u062f \u0627\u0644\u062f\u0631\u0627\u0633\u0629\u060c \u0648\u062a\u0645\u064a\u0632 \u0627\u0644\u062a\u062f\u062e\u0644\u0627\u062a \u0627\u0644\u0645\u0646\u0634\u0648\u0631\u0629 \u0639\u0646 \u0645\u0648\u0627\u062f \u0627\u0644\u0643\u062a\u0627\u0644\u0648\u062c. \u064a\u0645\u0643\u0646 \u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0635\u064a\u0627\u063a\u0629 \u0628\u0645\u0633\u0627\u0639\u062f\u0629 AI \u0644\u0644\u0647\u064a\u0643\u0644\u061b \u062a\u0638\u0644 \u0631\u0648\u0627\u0628\u0637 \u0627\u0644\u0645\u0635\u062f\u0631 \u0648\u062d\u062f\u0648\u062f \u0627\u0644\u0623\u062f\u0644\u0629 \u0645\u0631\u0626\u064a\u0629. \u0647\u0630\u0627 \u0627\u0644\u0639\u0645\u0644 \u0644\u064a\u0633 \u0645\u0631\u0627\u062c\u0639\u0629 \u0623\u0642\u0631\u0627\u0646 \u0645\u0633\u062a\u0642\u0644\u0629 \u0623\u0648 \u0646\u0635\u064a\u062d\u0629 \u0637\u0628\u064a\u0629.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/ar\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/posts\/451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/comments?post=451"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/posts\/451\/revisions"}],"predecessor-version":[{"id":520,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/posts\/451\/revisions\/520"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/media\/621"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/media?parent=451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/categories?post=451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/ar\/wp-json\/wp\/v2\/tags?post=451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}